{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:26:23Z","timestamp":1770506783926,"version":"3.49.0"},"reference-count":64,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.1080\/13543784.2025.2612321","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:06:49Z","timestamp":1767211609000},"page":"37-48","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Menin inhibitors for adult acute myeloid leukemia: 2025 update"],"prefix":"10.1080","volume":"35","author":[{"given":"Umar","family":"Iqbal","sequence":"first","affiliation":[{"name":"Moffitt Cancer Center","place":["Tampa, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Fadul","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center","place":["Tampa, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Sallman","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center","place":["Tampa, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rory M.","family":"Shallis","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center","place":["Tampa, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0025"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0492"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvv114"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1301689"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.01.033"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2019.01.024"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-025-10253-7"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S95279"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13070227"},{"key":"e_1_3_4_12_1","unstructured":"FDA approves revumenib for relapsed or refractory acute leukemia with a KMT2A translocation. 2024. Available from: https:\/\/wwwfdagov\/drugs\/resources-information-approved-drugs\/fda-approves-revumenib-relapsed-or-refractory-acute-leukemia-kmt2a-translocation2024"},{"key":"e_1_3_4_13_1","unstructured":"FDA approves revumenib for relapsed or refractory acute myeloid leukemia with a susceptible NPM1 mutation. Available from: https:\/\/wwwfdagov\/drugs\/resources-information-approved-drugs\/fda-approves-revumenib-relapsed-or-refractory-acute-myeloid-leukemia-susceptible-npm1-mutation2025"},{"key":"e_1_3_4_14_1","unstructured":"FDA approves ziftomenib for relapsed or refractory acute myeloid leukemia with a NPM1 mutation. Available from: https:\/\/wwwfdagov\/drugs\/resources-information-approved-drugs\/fda-approves-ziftomenib-relapsed-or-refractory-acute-myeloid-leukemia-npm1-mutation2025"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5311.404"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.09.025"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/17501911.2025.2485019"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2013.05.005"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.07.020"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1761"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107791"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-023-01270-1"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2017.05.023"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01877-1"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01004-y"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.08.005"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041177"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012806"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021359"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0160"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2024.103478"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.258186"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.773"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2015.04.026"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ange.201711828"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax5863"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00557-6"},{"key":"e_1_3_4_38_1","unstructured":"Aldoss I. EHA library. 2025 Jun 14;4160549:S1473."},{"key":"e_1_3_4_39_1","unstructured":"Arellano M. EHA library. 2025 Jun 14;4160543:S1467."},{"key":"e_1_3_4_40_1","unstructured":"Shukla N Guest E Tasian SK. Safety and activity of revumenib in combination with fludarabine\/cytarabine (FLA) in patients with relapsed\/refractory acute leukemias [abstract no. P450 plus presentation]."},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-204375"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00914"},{"key":"e_1_3_4_43_1","volume-title":"Ziftomenib in relapsed\/refractory (R\/R) NPM1-mutant acute myeloid leukemia (AML): phase 1b\/2 clinical activity and safety results from the pivotal KOMET-001 study","author":"Wang ES","year":"2025","unstructured":"Wang ES, Montesinos P, Issa GC, et al. Ziftomenib in relapsed\/refractory (R\/R) NPM1-mutant acute myeloid leukemia (AML): phase 1b\/2 clinical activity and safety results from the pivotal KOMET-001 study. American Society of Clinical Oncology; 2025."},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-198218"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-207106"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-207072"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-194827"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-198959"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-173149"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05812-3"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00826"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025028357"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70152"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/hematolrep16020024"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0560"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00386-3"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-199170"},{"key":"e_1_3_4_58_1","unstructured":"Wei A. EHA library. 2025 Jun 12;4159214:S137."},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05755-9"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-208887"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022480"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-185353"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-185561"},{"key":"e_1_3_4_64_1","unstructured":"NDA multidisciplinary review and evaluation. Application number: 218944Orig1s0002024."},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-2113"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.4c00311"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2025.2612321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T12:50:08Z","timestamp":1770382208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2025.2612321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"alternative-id":["10.1080\/13543784.2025.2612321"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2025.2612321","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}